CYTOKINETICS INC Weighted Average Number of Shares Outstanding, Diluted from 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Cytokinetics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to Q3 2025.
  • Cytokinetics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 120K shares, a 1.95% increase year-over-year.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 112K shares, a 16% increase from 2023.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 96.5K shares, a 7.46% increase from 2022.
  • Cytokinetics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 89.8K shares, a 16.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

CYTOKINETICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 120K +2.3K +1.95% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 119K +10.2K +9.35% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 118K +16.6K +16.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 112K +15.5K +16% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 118K +21.6K +22.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 109K +13.5K +14.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 102K +6.76K +7.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 96.5K +6.7K +7.46% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 96.1K +2.31K +2.47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 95.8K +10K +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 95.2K +10.2K +12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 89.8K Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 93.8K +13.4K +16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 85.7K +14K +19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 85K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q3 2021 80.3K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 71.8K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q3 2017 53.7M +10.5M +24.3% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-03
Q3 2016 43.2M +4.47M +11.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q3 2015 38.8M Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15

CYTOKINETICS INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 112K +15.5K +16% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 96.5K +6.7K +7.46% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 89.8K +12.9K +16.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 76.9K +12.4K +19.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 64.5K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2017 49.4M +6.84M +16.1% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-05
2016 42.6M +3.75M +9.65% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-05
2015 38.8M +3.11M +8.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 35.7M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2011 70.8M* +6.64M Jan 1, 2011 Dec 31, 2011 10-K 2012-03-13
2010 64.2M* Jan 1, 2010 Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.